Texas House Bill HB25

Texas 2025 - 89th 2nd C.S.

• Filed: 8/15/25
• Out of House Committee: 8/25/25
• Voted on by House: 8/27/25
• Out of Senate Committee: 8/27/25
• Voted on by Senate: 8/27/25
• Governor Action: 9/17/25

Impact

The bill is set to amend the Health and Safety Code by introducing a new chapter dedicated to the provisions surrounding ivermectin. This legislation creates a framework under which pharmacists can operate when dispensing ivermectin, while also ensuring that they are not subject to criminal or civil liability when following standardized protocols. This regulatory change is expected to affect how healthcare providers administer treatments involving ivermectin, which has been a subject of debate in recent public health discussions.

Summary

House Bill 25 (HB25) focuses on altering the regulations surrounding the dispensing of ivermectin by pharmacists in Texas. Under this bill, pharmacists are granted the authority to dispense ivermectin without requiring a prescription from a licensed healthcare practitioner. This legislation aims to enhance access to ivermectin for individuals who may benefit from its use, potentially simplifying the process for patients and reducing barriers associated with obtaining this medication.

Sentiment

The sentiment regarding HB25 appears to be mixed. Proponents argue that the bill encourages patient empowerment and enhances healthcare access, especially for individuals who may require ivermectin for certain medical conditions. However, there are concerns raised by detractors regarding the safety and efficacy of dispensing such medications without a prescription, questioning the oversight of pharmacists in these scenarios.

Contention

The primary contention surrounding HB25 revolves around the appropriateness of enabling pharmacists to dispense ivermectin without a prescription. Critics of the bill express concerns about potential misuse and the implications for patient safety, particularly in light of ongoing discussions about ivermectin's use in treating various conditions. While supporters view the law as a step forward in improving patient access to necessary treatments, opponents worry about the risk of undermining established medical protocols and patient care standards.